参考文献
［1］曹雷.帕金森病的麻醉［J］.中国实用医药，2009，（26）：181-182.
［2］de Lau LM，Breteler MM.Epidemiology of Parkinson's diseas［eJ］.Lancet Neurol，2006，5：525-535.
［3］Alves G，Forsaa EB，Pedersen KF，et al.Epidemiology of Parkinson's diseas［eJ］.J Neurol，2008，255（Suppl 5）：18-32.
［4］Crego-Vita D，Sanchez-Perez C，Gomez-Rico JAO，et al.Intracapsular hip fractures in the elderly.Do we know what is important？［J］.Injury，2017，48（3）：695-700.
［5］Bloem BR，Grimbergen YAM，Cramer M，et al.Prospective assessment of falls in Parkinson's diseas［eJ］.Journal of Neurology，2001，248（11）：950-958.
［6］Williams RD.Predictors of falls and fractures in bradykinetic rigid syndromes：a retrospective study［J］.Journal of Neurology，Neurosurgery&Psychiatry，2006，77（4）：468-473.
［7］Melton LJ，Leibson CL，Achenbach SJ，et al.Fracture risk after the diagnosis of Parkinson's disease：Influence of concomitant dementi［aJ］.Movement Disorders Official Journal of the Movement Disorder Society，2010，21（9）：1361-1367.
［8］吴志刚，沈丽霞.帕金森病患者下尿路功能障碍治疗研究进展［J］.神经药理学报，2014，4（4）：36-41.
［9］Badri AV，Purohit RS，Skenazy J，et al.A review of lower urinary tract symptoms in patients with Parkinson's diseas［eJ］.Curr Urol Rep，2014，15（9）：435-444.
［10］Przedborski S.The two-century journey of Parkinson disease research［J］.Nature Reviews Neuroscience，2017，18（4）：251-259.
［11］Checkoway H，Nelson LM.Epidemiologic approaches to the study of Parkinson's disease etiology［J］.Epidemiology，1999，10（3）：327-336.
［12］Mizuno Y，Mori H，Kondo T.Parkinson's disease：from etiology to treatmen［tJ］.Intern Med，1995，34（11）：1045-1054.
［13］Nicholson G.Parkinson's disease and anaesthesi［aJ］.British Journal of Anaesthesia，2002，89（6）：904-916.
［14］仓静，金琳.帕金森病患者的围手术期管理［J］.老年医学与保健，2013，（5）：276-278.
［15］Krygowska-Wajs A，Furgała A，Laskiewicz J，et al.Early diagnosis of orthostatic hypotension in idopathic Parkinson's disease［J］.Neurological Sciences，2002，43（1-2）：1-4.
［16］衣玉胜，殷积慧，王世端.帕金森病患者手术的麻醉处理［J］.中国医师进修杂志：综合版，2006，4（12）：73-74.
［17］Brennan KA，Genever RW.Managing Parkinson's disease during surgery［J］.BMJ，2010，341（7780）：990-993.
［18］Reilly DF，Mcneely MJ，Doerner D，et al.Self-reported Exercise Tolerance and the Risk of Serious Perioperative Complications［J］.Archives of Internal Medicine，1999，159（18）：2185-2192.
［19］Spiegel J.Peri-operative Management of Patients with Parkinson's Diseas［eJ］.American Journal of Medicine，2013，127（4）：275-280.
［20］Tomioka T，Ogaki N，Asari H.Anesthetic management of a Paget's disease patient complicated with Parkinson diseas［eJ］.Masui，1995，44（10）：1384-1387.
［21］Korchounov A，Kessler KR，Schipper HI.Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's diseas［eJ］.Acta Neurologica Scandinavica，2010，109（1）：45-51.
［22］Pereira JB，Per S，Daniel W，et al.Initial cognitive decline is associated with cortical thinning in early Parkinson disease［J］.Neurology，2014，82：2017-2025.
［23］Golden WE，Lavender RC，Metzer WS.Acute postoperative confusion and hallucinations in Parkinson disease［J］.Annals of Internal Medicine，1989，111（3）：218-222.
［24］Gray H，Wilson S，Sidebottom P，et al.Parkinson's disease and anaesthesi［aJ］.British Journal of Anaesthesia，2003，90（4）：524-525.
［25］Frost EA，Osborn I.Deep brain stimulation surgery for movement disorders and Parkinson's disease［J］.Int Anesthesiol Clin，2009，47：57-68.
［26］Khatib R，Ebrahim Z，Rezai A，et al.Perioperative events during deep brain stimulation：the experience at Cleveland clinic［J］.Neurosurg Anesthesiol，2008，20：36-40.
［27］Binder DK，Rau GM，Starr PA.Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorder［sJ］.Neurosurgery，2005，56（4）722-728.
［28］Umemura A，Jaggi JL，Hurtig HI.Deep brain stimulation for movement disorders：morbidity and mortality in 109 patient［sJ］.J Neurosurg，2003，98（4）：779-780.
［29］Frank MJ，Samanta J，Moustafa AA，et al.Hold your horses：impulsivity，deep brain stimulation，and medication in parkinsonism［J］.Science，2007，318：1309-1312.
［30］Oni OO，Mackenney RP.Total knee replacement in patients with Parkinson's diseas［eJ］.J Bone Joint Surg Br，1985，67（3）：424-425.
［31］Duffy GP，Trousdale RT.Total knee arthroplasty in patients with parkinson's diseas［eJ］.JArthroplasty，1996，11（8）：899-904.
［32］Erceg M，Maricevic′ A.Recurrent posterior dislocation following primary posterior-stabilized total knee arthroplasty［J］.Croat Med J，2000，41（2）：207-209.
［33］Fast A，Mendelsohn E，Sosner J.Total knee arthroplasty in Parkinson's diseas［eJ］.Arch Phys Med Rehabil，1994，75（11）：1269-1270.
［34］Shah SN，Hornyak J，Urquhart AG.Flexion contracture after total knee arthroplasty in a patient with Parkinson's disease：Successful treatment with botulinum toxin type A［J］.J Arthroplasty，2005，20（8）：1078-1080.
［35］Vince KG，Insall JN，Bannerman CE.Total knee arthroplasty in the patient with Parkinson's disease［J］.J Bone Joint Surg Br，1989，71（1）：51-54.
［36］Burrus MT，Werner BC，Cancienne JM，et al.Shoulder arthroplasty in patients with Parkinson's disease is associated with increased complication［sJ］.Journal of Shoulder and Elbow Surgery，2015，24（12）：1881-1887.
［37］Minville V，Chassery C，Benhaoua A，et al.Nerve Stimulator-Guided Brachial Plexus Block in a Patient with Severe Parkinson's Disease and Bilateral Deep Brain Stimulator［sJ］.Anesthesia &Analgesia，2006，102（4）：1296.
［38］Yamada K，Goto S.Kuratsu JI，et al.Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia：a retrospective evaluation of Japanese patients with Parkinson's diseas［eJ］.Parkinsonism &Related Disorders，2007，13（2）：101-107.
［39］Lefaucheur JP，Gurruchage JM，Bernard Pollin，et al.Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease：correlation with intra-operative multi-unit recordings but not with the type of anaesthesi［aJ］.Eur Neurol，2008，60（4）：186-199.
［40］Lin，S.H.，et al.，Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease：a preliminary study［J］.J Neurosurg，2008，109（2）：238-244.
［41］Hertel F，Züchner M，Weimar I，et al.Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesi［aJ］.Neurosurgery，2006，59（5）：E1138.
［42］Santos P，Valero R，Arguis MJ，et al.Preoperative adverse events during stereotactic microelectrode-guided deep brain surgery in Parkinson's diseas［eJ］.Rev Esp Anestesiol Reanim，2004.51（9）：523-530.
［43］Fukuda M，Kameyama S，Kawaguchi T，et al.Stereotaxy during intravenous anesthesia with propofo［J］.No Shinkei Geka，1998，26（8）：709-715.
［44］Krauss JK，Akeyson EW，Giam P，et al.Propofol-induced dyskinesias in Parkinson's diseas［eJ］.Anesth Analg，1996，83：420-422.
［45］Anderson BJ，Marks PV，Futter M E.Propofol-contrasting effects in movement disorder［sJ］.Br J Neurosurg，1994，8（3）：387-388.
［46］Deogaonkar A，Deogaonkar M，Lee JYK，et al.Propofol-induced dyskinesias controlled with dexmedetomidine during deep brain stimulation surgery［J］.Anesthesiology，2006，104（6）：1337-1339.
［47］詹中利.麻黄碱致帕金森病严重高血压反应一例［J］.内蒙古医学杂志，2010，42（4）：492.
［48］Brennan KA，Genever RW.Managing Parkinson's disease during surgery［J］.BMJ，2010，341：c5718.
［49］Stannard，Daphne.Incentive spirometry for preventing pulmonary complications after coronary artery bypass graft［J］.Journal of Perianesthesia Nursing，2013，28（4）：236-238.
［50］Kim YE，Kim HJ，Yun JY，et al.Intravenous amantadine is safe and effective for the perioperative management of patients with Parkinson's diseas［eJ］.J Neurol，2011，258（12）：2274-2275.